Yung Shin Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for YUNG SHIN PHARM
YUNG SHIN PHARM has eleven approved drugs.
Drugs and US Patents for Yung Shin Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yung Shin Pharm | DICLOFENAC SODIUM AND MISOPROSTOL | diclofenac sodium; misoprostol | TABLET, DELAYED RELEASE;ORAL | 205143-002 | Feb 19, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yung Shin Pharm | CLONIDINE HYDROCHLORIDE | clonidine hydrochloride | TABLET;ORAL | 202297-002 | Jun 13, 2013 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yung Shin Pharm | CEPHALEXIN | cephalexin | FOR SUSPENSION;ORAL | 065336-001 | Jul 25, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

